72 related articles for article (PubMed ID: 25425625)
1. Novel mechanism of voltage-gated N-type (Cav2.2) calcium channel inhibition revealed through α-conotoxin Vc1.1 activation of the GABA(B) receptor.
Huynh TG; Cuny H; Slesinger PA; Adams DJ
Mol Pharmacol; 2015 Feb; 87(2):240-50. PubMed ID: 25425625
[TBL] [Abstract][Full Text] [Related]
2. Conserved biophysical features of the Ca
Gauberg J; Abdallah S; Elkhatib W; Harracksingh AN; Piekut T; Stanley EF; Senatore A
J Biol Chem; 2020 Dec; 295(52):18553-18578. PubMed ID: 33097592
[TBL] [Abstract][Full Text] [Related]
3. Synaptotagmin-11 facilitates assembly of a presynaptic signaling complex in post-Golgi cargo vesicles.
Trovò L; Kouvaros S; Schwenk J; Fernandez-Fernandez D; Fritzius T; Rem PD; Früh S; Gassmann M; Fakler B; Bischofberger J; Bettler B
EMBO Rep; 2024 Jun; 25(6):2610-2634. PubMed ID: 38698221
[TBL] [Abstract][Full Text] [Related]
4. An orally available Ca
Kutzsche J; Guzman GA; Willuweit A; Kletke O; Wollert E; Gering I; Jürgens D; Breitkreutz J; Stark H; Beck-Sickinger AG; Klöcker N; Hidalgo P; Willbold D
Br J Pharmacol; 2024 Jun; 181(12):1734-1756. PubMed ID: 38157867
[TBL] [Abstract][Full Text] [Related]
5. Dual Antagonism of α9α10 nAChR and GABA
Li X; Tae HS; Chen S; Yousuf A; Huang L; Zhang J; Jiang T; Adams DJ; Yu R
J Med Chem; 2024 Jan; 67(2):971-987. PubMed ID: 38217860
[TBL] [Abstract][Full Text] [Related]
6. Expression and functions of N-type Cav2.2 and T-type Cav3.1 channels in rat vasopressin neurons under normotonic conditions.
Sato-Numata K; Numata T; Ueta Y; Okada Y
J Physiol Sci; 2020 Oct; 70(1):49. PubMed ID: 33059597
[TBL] [Abstract][Full Text] [Related]
7. Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.
Feldman P; Khanna R
Neurosci Lett; 2013 Dec; 557 Pt A(0 0):27-36. PubMed ID: 23831344
[TBL] [Abstract][Full Text] [Related]
8. Alkyne-Bridged α-Conotoxin Vc1.1 Potently Reverses Mechanical Allodynia in Neuropathic Pain Models.
Belgi A; Burnley JV; MacRaild CA; Chhabra S; Elnahriry KA; Robinson SD; Gooding SG; Tae HS; Bartels P; Sadeghi M; Zhao FY; Wei H; Spanswick D; Adams DJ; Norton RS; Robinson AJ
J Med Chem; 2021 Mar; 64(6):3222-3233. PubMed ID: 33724033
[TBL] [Abstract][Full Text] [Related]
9. A peptidomimetic modulator of the Ca
Gomez K; Santiago U; Nelson TS; Allen HN; Calderon-Rivera A; Hestehave S; Rodríguez Palma EJ; Zhou Y; Duran P; Loya-Lopez S; Zhu E; Kumar U; Shields R; Koseli E; McKiver B; Giuvelis D; Zuo W; Inyang KE; Dorame A; Chefdeville A; Ran D; Perez-Miller S; Lu Y; Liu X; Handoko ; Arora PS; Patek M; Moutal A; Khanna M; Hu H; Laumet G; King T; Wang J; Damaj MI; Korczeniewska OA; Camacho CJ; Khanna R
Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2305215120. PubMed ID: 37972067
[TBL] [Abstract][Full Text] [Related]
10. ω-Phonetoxins inhibit voltage-gated calcium Ca
Castro-Junior C; Gomez MV; Borges MH; Lipscombe D; Andrade A
bioRxiv; 2023 Aug; ():. PubMed ID: 37693414
[TBL] [Abstract][Full Text] [Related]
11. Comparison of quinazoline and benzoylpyrazoline chemotypes targeting the CaVα-β interaction as antagonists of the N-type CaV2.2 channel.
Ran D; Gomez K; Moutal A; Patek M; Perez-Miller S; Khanna R
Channels (Austin); 2021 Dec; 15(1):128-135. PubMed ID: 33416017
[TBL] [Abstract][Full Text] [Related]
12. Ankyrin B and Ankyrin B variants differentially modulate intracellular and surface Cav2.1 levels.
Choi CSW; Souza IA; Sanchez-Arias JC; Zamponi GW; Arbour LT; Swayne LA
Mol Brain; 2019 Sep; 12(1):75. PubMed ID: 31477143
[TBL] [Abstract][Full Text] [Related]
13. The Interplay Between Splicing of Two Exon Combinations Differentially Affects Membrane Targeting and Function of Human Ca
Dahimene S; Page KM; Nieto-Rostro M; Pratt WS; Dolphin AC
Function (Oxf); 2024; 5(1):zqad060. PubMed ID: 38020068
[TBL] [Abstract][Full Text] [Related]
14. The intracellular C-terminus confers compartment-specific targeting of voltage-gated Ca
Chin M; Kaeser PS
bioRxiv; 2023 Dec; ():. PubMed ID: 38187530
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into the allosteric effects of the antiepileptic drug topiramate on the Ca
Gao Y; Bai Q; Zhang XC; Zhao Y
Biochem Biophys Res Commun; 2024 Jun; 725():150271. PubMed ID: 38901222
[TBL] [Abstract][Full Text] [Related]
16. A PEPTIDE UNCOUPLING CRMP-2 FROM THE PRESYNAPTIC Ca(2+) CHANNEL COMPLEX DEMONSTRATES EFFICACY IN ANIMAL MODELS OF MIGRAINE AND AIDS THERAPY-INDUCED NEUROPATHY.
Ripsch MS; Ballard CJ; Khanna M; Hurley JH; White FA; Khanna R
Transl Neurosci; 2012 Mar; 3(1):1-8. PubMed ID: 22662308
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling the CRMP2-Ca
Allen HN; Hestehave S; Duran P; Nelson TS; Khanna R
bioRxiv; 2024 Jun; ():. PubMed ID: 38895294
[TBL] [Abstract][Full Text] [Related]
18. Expression of Concern: Association between Genetic Polymorphisms in Cav2.3 (R-type) Ca2+ Channels and Fentanyl Sensitivity in Patients Undergoing Painful Cosmetic Surgery.
PLOS ONE Editors
PLoS One; 2023; 18(1):e0278809. PubMed ID: 36630347
[No Abstract] [Full Text] [Related]
19. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors.
François-Moutal L; Wang Y; Moutal A; Cottier KE; Melemedjian OK; Yang X; Wang Y; Ju W; Largent-Milnes TM; Khanna M; Vanderah TW; Khanna R
Pain; 2015 Jul; 156(7):1247-1264. PubMed ID: 25782368
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of presynaptic calcium transients in cortical inputs to the dorsolateral striatum by metabotropic GABA(B) and mGlu2/3 receptors.
Kupferschmidt DA; Lovinger DM
J Physiol; 2015 May; 593(10):2295-310. PubMed ID: 25781000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
